What Are Wall Street Analysts' Target Price for Agilent Technologies Stock?

The article is a Wall Street analyst outlook piece on Agilent Technologies (A), highlighting that the stock has materially outperformed both the broader market and healthcare peers. Agilent is up 33.1% over the past 52 weeks and 16.5% year to date, helped by strong Q2 2026 results on May 27, when shares surged 16.9% after the company posted 10% revenue growth to $1.83 billion, 14% growth in adjusted EPS to $1.49, and raised full-year guidance. Analyst sentiment remains constructive: 20 analysts rate the stock a Moderate Buy, with Morgan Stanley lifting its price target to $175 on Aug. 17. The consensus price target of $159.21 suggests only modest upside from current levels, while the Street-high target of $185 implies 16.5% upside. Overall, the piece signals continued bullish sentiment but indicates much of the recent good news may already be reflected in the share price.